TWD 27.4
(1.29%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 9.01 Million TWD | -59.02% |
2022 | 22.03 Million TWD | -39.1% |
2021 | 35.86 Million TWD | -35.12% |
2020 | 55.44 Million TWD | 42.47% |
2019 | 39.07 Million TWD | 104.76% |
2018 | 18.88 Million TWD | -2.44% |
2017 | 19.47 Million TWD | 231.84% |
2016 | -14.77 Million TWD | -884.96% |
2015 | 1.87 Million TWD | 379.64% |
2014 | -462 Thousand TWD | -119.11% |
2013 | 3.51 Million TWD | -77.98% |
2012 | 16.07 Million TWD | -47.82% |
2011 | 30.61 Million TWD | -23.27% |
2010 | 39.97 Million TWD | -28.67% |
2009 | 55.99 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 7.51 Million TWD | -16.01% |
2024 Q1 | 8.93 Million TWD | 1658.71% |
2023 Q3 | 4.53 Million TWD | -1.05% |
2023 Q1 | 440 Thousand TWD | 114.4% |
2023 Q4 | -588 Thousand TWD | -112.96% |
2023 Q2 | 4.58 Million TWD | 942.27% |
2023 FY | - TWD | -59.02% |
2022 Q3 | 7.41 Million TWD | -17.9% |
2022 FY | - TWD | -39.1% |
2022 Q4 | -3.05 Million TWD | -141.22% |
2022 Q2 | 9.02 Million TWD | 5.96% |
2022 Q1 | 8.51 Million TWD | 14.04% |
2021 Q1 | 11.3 Million TWD | -25.89% |
2021 Q2 | 14.16 Million TWD | 25.35% |
2021 Q3 | 3.01 Million TWD | -78.69% |
2021 Q4 | 7.47 Million TWD | 147.43% |
2021 FY | - TWD | -35.12% |
2020 FY | - TWD | 42.47% |
2020 Q2 | 15.76 Million TWD | -19.94% |
2020 Q3 | 4.72 Million TWD | -70.06% |
2020 Q4 | 15.25 Million TWD | 223.16% |
2020 Q1 | 19.69 Million TWD | 38.36% |
2019 Q3 | 12.47 Million TWD | 193.67% |
2019 FY | - TWD | 104.76% |
2019 Q1 | 7.95 Million TWD | -28.26% |
2019 Q4 | 14.23 Million TWD | 14.08% |
2019 Q2 | 4.24 Million TWD | -46.57% |
2018 Q3 | 1.39 Million TWD | -42.73% |
2018 Q4 | 11.08 Million TWD | 694.91% |
2018 FY | - TWD | -2.44% |
2018 Q1 | 4.09 Million TWD | -53.17% |
2018 Q2 | 2.43 Million TWD | -40.5% |
2017 Q2 | 3.7 Million TWD | 349.26% |
2017 FY | - TWD | 231.84% |
2017 Q1 | -1.48 Million TWD | 84.7% |
2017 Q3 | 8.52 Million TWD | 130.08% |
2017 Q4 | 8.73 Million TWD | 2.51% |
2016 Q1 | 2.64 Million TWD | 403.21% |
2016 FY | - TWD | -884.96% |
2016 Q4 | -9.71 Million TWD | -175.29% |
2016 Q2 | -4.17 Million TWD | -257.76% |
2016 Q3 | -3.52 Million TWD | 15.49% |
2015 Q1 | 1.45 Million TWD | 126.91% |
2015 Q4 | -873 Thousand TWD | -122.72% |
2015 Q3 | 3.84 Million TWD | 251.26% |
2015 FY | - TWD | 379.64% |
2015 Q2 | -2.54 Million TWD | -274.81% |
2014 Q4 | -5.4 Million TWD | -44.58% |
2014 Q3 | -3.73 Million TWD | -1443.53% |
2014 Q2 | 278 Thousand TWD | -96.6% |
2014 Q1 | 8.18 Million TWD | 489.34% |
2014 FY | - TWD | -119.11% |
2013 Q3 | -1.14 Million TWD | -215.02% |
2013 Q1 | 5.77 Million TWD | -37.76% |
2013 FY | - TWD | -77.98% |
2013 Q4 | -2.1 Million TWD | -82.94% |
2013 Q2 | 999 Thousand TWD | -82.7% |
2012 Q1 | -484 Thousand TWD | -124.52% |
2012 Q2 | 1.76 Million TWD | 465.5% |
2012 Q3 | 5.25 Million TWD | 196.95% |
2012 Q4 | 9.27 Million TWD | 76.6% |
2012 FY | - TWD | -47.82% |
2011 Q4 | 1.97 Million TWD | -85.39% |
2011 Q1 | 10.81 Million TWD | 36.78% |
2011 Q2 | 4.32 Million TWD | -60.07% |
2011 FY | - TWD | -23.27% |
2011 Q3 | 13.51 Million TWD | 212.78% |
2010 Q4 | 7.91 Million TWD | -34.13% |
2010 FY | - TWD | -28.67% |
2010 Q3 | 12 Million TWD | 119.18% |
2010 Q1 | 14.59 Million TWD | 0.0% |
2010 Q2 | 5.47 Million TWD | -62.46% |
2009 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Farcent Enterprise Co.,Ltd | 355.04 Million TWD | 97.461% |
Taiyen Biotech Co., Ltd. | 518.26 Million TWD | 98.261% |
Sanitar Co., Ltd. | 401.77 Million TWD | 97.756% |
Chlitina Holding Limited | 1.96 Billion TWD | 99.542% |
Jourdeness Group Limited | 802.68 Million TWD | 98.877% |
Nan Liu Enterprise Co., Ltd. | 798.8 Million TWD | 98.871% |
Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | 92.531% |
San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | 97.32% |
Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | 99.461% |
KNH Enterprise Co., Ltd. | 1.41 Billion TWD | 99.363% |